TNM residual tumor classification revisited - PubMed (original) (raw)
. 2002 May 1;94(9):2511-6.
doi: 10.1002/cncr.10492.
Affiliations
- PMID: 12015777
- DOI: 10.1002/cncr.10492
Free article
TNM residual tumor classification revisited
Christian Wittekind et al. Cancer. 2002.
Free article
Abstract
Background: For cancer patients, prognosis is strongly influenced by the completeness of tumor removal at the time of cancer-directed surgery or disease remission after nonsurgical treatment with curative intent. These parameters define the relative success of definitive treatment and can be codified by an additional subclassification within the TNM system, the residual tumor (R) classification. Despite the importance of residual tumor status in designing clinical management after treatment, misinterpretation and inconsistent application of the R classification frequently occur that diminish or abrogate its clinical utility.
Methods: An analysis of the relevant literature regarding the use and prognostic importance of the R classification was undertaken.
Results: In the current study, the prognostic importance of the R classification for different kinds of tumors is discussed. Problems that arise in using the R classification are described. Special issues regarding the use of the R classification are addressed.
Conclusions: The R classification is a strong indicator of prognosis and facilitates the comparison of treatment results if applied in a consistent manner. Uniform use and interpretation of this classification is essential for the standardization of posttreatment data collection.
Copyright 2002 American Cancer Society.DOI 10.1002/cncr.10492
Similar articles
- [Use and problems of the TNM classification].
Wittekind C. Wittekind C. Verh Dtsch Ges Pathol. 2006;90:142-50. Verh Dtsch Ges Pathol. 2006. PMID: 17867591 German. - A uniform residual tumor (R) classification: integration of the R classification and the circumferential margin status.
Wittekind C, Compton C, Quirke P, Nagtegaal I, Merkel S, Hermanek P, Sobin LH. Wittekind C, et al. Cancer. 2009 Aug 1;115(15):3483-8. doi: 10.1002/cncr.24320. Cancer. 2009. PMID: 19536900 - TNM: evolution and relation to other prognostic factors.
Sobin LH. Sobin LH. Semin Surg Oncol. 2003;21(1):3-7. doi: 10.1002/ssu.10014. Semin Surg Oncol. 2003. PMID: 12923909 - [Minimal residual disease in gastrointestinal tumors: tumor detection in bone marrow, blood and lymph nodes].
Rosenberg R, Nekarda H, Thorban S, Siewert JR. Rosenberg R, et al. Acta Med Austriaca Suppl. 2002;59:42-53. Acta Med Austriaca Suppl. 2002. PMID: 12506760 Review. German.
Cited by
- The misunderstanding of the R Classification-a survey amongst medical specialties treating breast cancer.
Sunitsch S, Fischer P, Pregartner G, Regitnig P. Sunitsch S, et al. Virchows Arch. 2024 Sep;485(3):479-490. doi: 10.1007/s00428-024-03876-8. Epub 2024 Jul 22. Virchows Arch. 2024. PMID: 39037644 Free PMC article. - Clinical Perspectives on Surgical Reconstruction of Eccentric Tumors at the Distal Femur with Unicondylar Resection.
Hu X, Wang C, Zeng Y, Yang X, Min L. Hu X, et al. Orthop Surg. 2024 Aug;16(8):1761-1769. doi: 10.1111/os.14119. Epub 2024 Jun 24. Orthop Surg. 2024. PMID: 38923385 Free PMC article. Review. - Intentional Dural Resection during en bloc Spinal Resection Could Provide a Secure Surgical Margin for Patients with Recurrent Spinal Tumors.
Du Z, Tang X, Cai Z, Wang H, Wei R, Wang J. Du Z, et al. Orthop Surg. 2024 Aug;16(8):1753-1760. doi: 10.1111/os.14104. Epub 2024 Jun 10. Orthop Surg. 2024. PMID: 38859700 Free PMC article. Review. - Improved Metastatic-Free Survival after Systematic Re-Excision Following Complete Macroscopic Unplanned Excision of Limb or Trunk Soft Tissue Sarcoma.
Gouin F, Michot A, Jafari M, Honoré C, Mattei JC, Rochwerger A, Ropars M, Tzanis D, Anract P, Carrere S, Gangloff D, Ducoulombier A, Lebbe C, Guiramand J, Waast D, Marchal F, Sirveaux F, Causeret S, Gimbergues P, Fiorenza F, Paquette B, Soibinet P, Guilloit JM, Le Nail LR, Dujardin F, Brinkert D, Chemin-Airiau C, Morelle M, Meeus P, Karanian M, Le Loarer F, Vaz G, Blay JY; NETSARC/RREPS and French Sarcoma Group-Groupe d’Etude des Tumeurs Osseuses (GSF-GETO) Networks. Gouin F, et al. Cancers (Basel). 2024 Mar 30;16(7):1365. doi: 10.3390/cancers16071365. Cancers (Basel). 2024. PMID: 38611043 Free PMC article. - Development of a gastric cancer risk calculator for questionnaire-based surveillance of Iranian dyspeptic patients.
Gohari K, Saberi S, Esmaieli M, Tashakoripour M, Hosseini ME, Nahvijou A, Mohagheghi MA, Kazemnejad A, Mohammadi M. Gohari K, et al. BMC Gastroenterol. 2024 Jan 18;24(1):39. doi: 10.1186/s12876-024-03123-z. BMC Gastroenterol. 2024. PMID: 38238682 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources